Home

interiore critico Credenza pbc clinical trials Dedurre profondità saggezza

Overview - Cholestatic Liver Diseases Lab - Mayo Clinic Research
Overview - Cholestatic Liver Diseases Lab - Mayo Clinic Research

GSK - Clinical Research Study into itch in PBC | PBC
GSK - Clinical Research Study into itch in PBC | PBC

PBC Research – PBC Society Canada
PBC Research – PBC Society Canada

Genfit - Clinical Trial for those with limited response to URSO | PBC
Genfit - Clinical Trial for those with limited response to URSO | PBC

Zydus starts phase 2(b) clinical trials of Saroglitazar Mg in Primary  Biliary Cholangitis - The Hindu BusinessLine
Zydus starts phase 2(b) clinical trials of Saroglitazar Mg in Primary Biliary Cholangitis - The Hindu BusinessLine

Real-world experience with obeticholic acid in patients with primary  biliary cholangitis - ScienceDirect
Real-world experience with obeticholic acid in patients with primary biliary cholangitis - ScienceDirect

Definition and Management of Patients With Primary Biliary Cholangitis and  an Incomplete Response to Therapy - ScienceDirect
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy - ScienceDirect

Primary and secondary end points of POISE trial comparing obeticholic... |  Download Scientific Diagram
Primary and secondary end points of POISE trial comparing obeticholic... | Download Scientific Diagram

New European Guidelines for PBC Diagnosis and Treatment – PBC Society Canada
New European Guidelines for PBC Diagnosis and Treatment – PBC Society Canada

Efficacy – OCALIVA® (obeticholic acid) | Official US HCP Site
Efficacy – OCALIVA® (obeticholic acid) | Official US HCP Site

Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap  syndrome: Characteristics and response to obeticholic acid
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid

Gastroenterology Clinical Trials - Fort Worth, TX | GI Alliance
Gastroenterology Clinical Trials - Fort Worth, TX | GI Alliance

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary  Cholangitis | NEJM
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis | NEJM

Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology,  Diagnostics, and New Therapeutic Approaches
Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches

A randomized placebo-controlled trial of elafibranor in patients with  primary biliary cholangitis and incomplete response to UDCA - Journal of  Hepatology
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA - Journal of Hepatology

Clinical Trials
Clinical Trials

6047
6047

New treatments/targets for primary biliary cholangitis - JHEP Reports
New treatments/targets for primary biliary cholangitis - JHEP Reports

A placebo-controlled randomised trial of budesonide for PBC following an  insufficient response to UDCA - Journal of Hepatology
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA - Journal of Hepatology

Management pillars of primary biliary cholangitis. ALP, alkaline... |  Download Scientific Diagram
Management pillars of primary biliary cholangitis. ALP, alkaline... | Download Scientific Diagram

Proof of Concept clinical trial – Australia & New Zealand – PBC Society  Canada
Proof of Concept clinical trial – Australia & New Zealand – PBC Society Canada

Seladelpar effective, safe in PBC with cirrhosis
Seladelpar effective, safe in PBC with cirrhosis

Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at  AASLD event - Express Pharma
Zydus to present PBC and NASH clinical trial data of Saroglitazar Mg at AASLD event - Express Pharma

PBC and PSC – PSC Support
PBC and PSC – PSC Support